Top 5 Performing Stocks For 2019


Source: ThinkstockMay 30, 2018: The S&P 500 closed up 1.3% at 2,724.08. The DJIA closed up 1.3% at 24,668.75. Separately, the Nasdaq was up 0.9% at 7,462.45.

Wednesday was a solid recovery for the broad U.S. markets after a slow start to this shortened trading week. Crude oil also saw a big recovery in Wednesdays session. The S&P 500 sectors were entirely positive. The most positive sectors were energy and financials up 3.1% and 1.8%, respectively. The worst performing sectors were utilities and technology up 0.8% and 0.7% respectively.


Crude oil was last seen trading up 2.3% at $68.29.

Gold was last seen trading flat at $1,306.60.

The S&P 500 stock posting the largest daily percentage loss ahead of the close was Michael Kors Holdings Limited (NYSE: KORS) which traded down about 12% at $60.05. The stocks 52-week range is $32.38 to $70.00. Volume was roughly 17 million compared to the daily average volume of 1.9 million.

Top 5 Performing Stocks For 2019: CVR Partners LP(UAN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CVR Partners (NYSE: UAN) and PotashCorp (NYSE:NTR) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

  • [By Max Byerly]

    Arcadia Biosciences (NASDAQ: RKDA) and CVR Partners (NYSE:UAN) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

Top 5 Performing Stocks For 2019: Alexion Pharmaceuticals, Inc.(ALXN)


Advisors’ Opinion:

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.s (NASDAQ: ALXN) short interest dropped to 3.99 million shares from the previous level of 4.37 million. Shares were trading at $122.43, in a 52-week range of $102.10 to $149.34.

  • [By ]

    Alexion Pharmaceuticals Inc. (ALXN) is a U.S. pharma stock best known for its development of rare blood disorder drug Soliris. So far this drug has proved extremely successful. And now, the company is looking to expand into further treatment opportunities. The company is on the verge of snapping up Sweden’s Wilson Therapeutics for $855 million, further boosting (and diversifying) its rare disease lineup.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Joseph Griffin]

    Alexion Pharmaceuticals (NASDAQ:ALXN) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Saturday.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) is scheduled to reveal its first-quarter results Thursday morning. The consensus forecast calls for EPS of $1.50 and $922.99 million in revenue. Shares were trading at $107.78 on Fridays close. The consensus price target is $158.60, while the 52-week range is $96.18 to $149.34.

Top 5 Performing Stocks For 2019: Zogenix, Inc.(ZGNX)


Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Zogenix (ZGNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    Here’s what you need to know about the catalysts that could send these stocks soaring, or plummeting, in the third quarter.

    Company Market Cap Incoming Catalyst
    Spark Therapeutics Inc. (NASDAQ:ONCE) $3.09 billion Clinical trial results
    Zogenix, Inc. (NASDAQ:ZGNX) $1.56 billion Clinical trial results
    Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) $593 million PDUFA date


    Data source: Yahoo! Finance.

  • [By Logan Wallace]

    DekaBank Deutsche Girozentrale bought a new stake in Zogenix (NASDAQ:ZGNX) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 14,700 shares of the company’s stock, valued at approximately $575,000.

Top 5 Performing Stocks For 2019: Porter Bancorp Inc.(PBIB)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Porter Bancorp (NASDAQ:PBIB) have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Porter Bancorp earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 44.3359026173577 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By WWW.GURUFOCUS.COM]

    For the details of PATRIOT FINANCIAL PARTNERS GP, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PATRIOT+FINANCIAL+PARTNERS+GP%2C+LP

    These are the top 5 holdings of PATRIOT FINANCIAL PARTNERS GP, LPBanc of California Inc (BANC) – 2,850,564 shares, 32.49% of the total portfolio. Meta Financial Group Inc (CASH) – 397,069 shares, 25.6% of the total portfolio. Guaranty Bancorp (GBNK) – 1,391,767 shares, 23.3% of the total portfolio. MBT Financial Corp (MBTF) – 2,060,302 shares, 13.08% of the total portfolio. Sterling Bancorp (STL) – 323,980 shares, 4.31% of the total portfolio.

Top 5 Performing Stocks For 2019: First Citizens BancShares, Inc.(FCNCA)

Advisors’ Opinion:

  • [By Max Byerly]

    American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Capital City Bank Group (NASDAQ: CCBG) and First Citizens BancShares (NASDAQ:FCNCA) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

Leave a Reply

Your email address will not be published. Required fields are marked *